Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaasFlex: Dapagliflozin effects on nocturnal substrate oxidation
NCT03721874Phase 4Completed
- Sponsor
- Maastricht University
- Start
- Apr 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in prediabetes, sponsored by Maastricht University. Started Apr 2019; status: completed.
02
Drugs
dapagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT03721874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721874.